Looking the price of JNJ in an interesting level after a brutal sell off.
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral...
Here is my view on JNJ; it is at a support level in a very long uptrend; There is a potential of 15% appreciation if taking profit before the resistance level on cash equity without using leverage. If using leverage, I'd risk 5% from my trading capital and put a SL below the support area, the Reward to risk will be around 6 to 1 or 30%.
Hi, The market has made some pretty good moves up and the current slight correction is bringing prices back to technically good levels and Johnson & Johnson is one of them. Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer goods. Technically, it has been quite difficult...
Not much to say, JNJ is in my portfolio and with this chart, I open one more trade
The trendline is the most common part of technical analysis in forex trading. But when compared to support and resistance, trendlines are less commonly used. The trendline should be more significant due to the number of touches. Trendlines are very suitable in combination with several technical indicators, one of which is the Money Flow Index ( MFI ). MFI is an...
This is my expectations in the market, what I'm looking at in my watchlist and the economic data
Both macro (lawsuit, bankrupcy denied to mitigate fines) and technical points to downside in the short term. Here we see a head and soulders formation, with downside target coinciding with monthly 100 SME. Strong support for long term hold.
The PEAD projected a Bullish outlook for $JNJ after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 50%.
Johnson & Johnson has rejected the Heartline of the Equidistant Channel while showing Bearish Divergence on the MACD and RSI and as a result i now think it will be heading for a minimum .382-.618 Retrace and i will be playing it via monthly put options.
yyr56y56y5y445y5y45y5454y54yy455y45yy5y5y5y45y5yrthrththrthrtrhrthrth
Has broken to the downside, the initial moves retracement looks to be done, setting up for another leg down.
Watch for follow through with no more than a 50% retracement at open
www.economiaendigerido.com.ar Análisis de JNJ para Miguel. Pedime activos y los vemos.
Sorry but a company responsible for the opioid pandemic is probably not on my investment list for sure pretty much a legal drug lord in my opinion how do not have records of how much drugs you make sounds a little fishy
Falling Wedge Pattern Breakout and Retest Formation of HH and HL Support from 61% fib retracement Entry after formation of HL (176.34) Trade with specified Stop Loss TP levels are specified Ride the trend with trailing stop Loss Manage your risk accordingly
JNJ fundamentally is a cross between Big Pharm and Consumer Staples Recent Earnings were solid not spectacular but the latter is not expected here. Technically, JNJ climbs higher without much volatility, At the moment it is rising in a small cycle within the supertrend. Strength is increasing and some bearish momentum is exhausting. This is a low-beta stock...